Skip to main content
TipRanks
Go Ultimate75% OFF

Nuwellis (NUWE) Stock Price & Analysis

756 Followers

NUWE Stock Chart & Stats

$3.89-$0.21(-5.12%)
At close: 4:00 PM EST
$2.5$5$7.5$10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$3.83 - $4.12
52-Week Range
$2.52 - $1,555.79
Previous Close
$4.10
Volume
N/A
Average Volume (3M)
1.41M
Market Cap
$2.10M
Enterprise Value
-$5.95M
Total Cash (Recent Filing)
$8.29M
Total Debt (Recent Filing)
$135.00K
Price to Earnings (P/E)
―
Beta
1.94
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring Revenue Model

Aquadex combines system placements with recurring circuit purchases, linking revenue to procedure utilization rather than one-time equipment sales alone. The installed base and presence across about 135 hospital accounts can support repeat demand and deepen customer relationships as clinical adoption expands.

Pediatric And Revenue Growth

Growth in revenue, console placements, and pediatric sales indicates expanding adoption in a strategically important segment. More installed consoles can enlarge the future consumables base, while pediatric momentum broadens the company’s clinical reach and supports longer-term utilization growth.

Improving Gross Margin And Costs

Higher gross margin alongside lower operating expenses shows progress toward a more efficient operating model. If sustained as product mix and scale improve, these gains can reduce the earnings burden from the company’s fixed cost base and strengthen its path toward better cash conversion.

Bears Say

Persistent Cash Burn

Materially negative operating and free cash flow means the business is consuming cash to operate rather than funding itself internally. Continued burn can restrict investment flexibility and increase reliance on additional financing before the company reaches sustainable profitability.

Deep Operating Losses

Strong gross margin has not yet translated into viable overall economics because operating expenses remain far above gross profit. Persistently large operating and net losses indicate that substantial growth or further cost reductions are required before the model can approach break-even.

Unstable Top-Line Performance

The broader revenue contraction and uneven quarterly performance make the growth trajectory less dependable. Flat revenue and lower console sales can slow expansion of the installed base and reduce the pace at which recurring circuit revenue develops over the next several quarters.

Nuwellis News

NUWE FAQ

What was Nuwellis’s price range in the past 12 months?
Nuwellis lowest stock price was $2.52 and its highest was $1555.79 in the past 12 months.
What is Nuwellis’s market cap?
Nuwellis’s market cap is $2.10M.
When is Nuwellis’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuwellis’s earnings last quarter?
Nuwellis released its earnings results on Nov 12, 2026. The company reported -$5.81 earnings per share for the quarter.
Is Nuwellis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nuwellis pay dividends?
Nuwellis does not currently pay dividends.
What is Nuwellis’s EPS estimate?
Nuwellis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuwellis have?
Nuwellis has 540,916 shares outstanding.
What happened to Nuwellis’s price movement after its last earnings report?
Nuwellis reported an EPS of -$5.81 in its last earnings report. Following the earnings report the stock price went down -9.042%.
Which hedge fund is a major shareholder of Nuwellis?
Currently, no hedge funds are holding shares in NUWE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology